에 대한 최신 뉴스 Veeva Systems (NYSE:VEEV) 주식

VEEVA SYSTEMS INC-CLASS A

Veeva Systems

Veeva Sys

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Cathie Wood Offloads Meta Stock While Mark Zuckerberg Celebrates Llama AI Success

Equities

News

Markets

ETFs

ABSI

AMGN

ARKG

ARKK

ARKQ

ARKX

BEAM

ILMN

IRDM

PACB

RPTX

VEEV

2025년 3월 21일 금요일, 캐시 우드가 이끄는 아크 인베스트는 몇 가지 주목할 만한 거래를 진행했으며, 여기에는 상당한 매수와 매도가 포함되었다. 아크 인베스트의 펀드는 이리듐 커뮤니케이션스(NASDAQ:IRDM), 빔 테라퓨틱스(NASDAQ:BEAM), 퍼시픽 바이오사이언스 오브 캘리포니아(NASDAQ:PACB), 및 앱시 코퍼레이션(NASDAQ:ABSI)를 매수한 반면, 일루미나(NASDAQ:ILMN), 리페어 테라퓨틱스(NASDAQ:RPTX), 암젠(NASDAQ:AMGN), 및 비바 시스템즈(NYSE:VEEV)의 주식을 매도했다.

아크 인베스트가 이리듐·빔·퍼시픽 바이오사이언스를 매수, 일루미나와 암젠을 매각

Earnings

Pre-Market Outlook

Trading Ideas

목요일(6일) 아침 미국 주식 선물이 하락하는 가운데, 투자자들의 관심을 끌 수 있는 주식들이 다음과 같다. 크로거, BJ&#39;s 홀세일 클럽, 비바 시스템즈, 메이시스 및 휴렛 팩커드 엔터프라이즈

목요일 주목해야 할 주식: 크로거, BJ&#39;s 홀세일 클럽, 비바 시스템즈, 메이시스 및 휴렛 팩커드 엔터프라이즈

A,Woman,Sits,At,A,Desk,With,A,Laptop,Open,

General

AMZN

GOOG

GOOGL

iShares Trust Dow Jones US Financial Services Index Fund

MSFT

원격 근무와 사무실 근무 의무에 대한 논쟁이 계속되는 가운데, 비바 시스템즈(NYSE:VEEV), 클라우드 기반 소프트웨어 회사가 주목받고 있습. 이는 원격 근무(WFH) 정책을 수용하는 것이 어떻게 성공적인 전략이 될 수 있는지를 보여주는 대표적인 사례이다.

원격 근무 vs 오피스 복귀: 비바의 유연성이 JP모건의 사무실 지침을 능가할 수 있을까?

Veeva Systems Inc

Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) has outperformed the market over the past 10 years by 14.08% on an annualized basis producing an average annual return of 24.34%. Currently, Veeva Systems has a market capitalization of $38.02 billion. 
Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 10 years ago, it would be worth $856.95 today based on a price of $233.69 for VEEV at the time of writing.
<h3>Veeva Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746044125_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today

<a href="https://www.veeva.com/">Veeva Systems</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) today announced <a href="https://www.veeva.com/AI">Veeva AI</a>, a major new initiative that adds AI to the Veeva Vault Platform and Veeva applications to help life sciences companies automate tasks and improve employee productivity using AI Agents and AI Shortcuts. Veeva AI provides a fast and efficient way to introduce application-specific AI Agents based on large language models (LLMs) into existing Veeva applications and enable end users with AI Shortcuts. Veeva AI will work in all Veeva applications across all major areas, including clinical, regulatory, safety, quality, medical, and commercial.
&nbsp;
Veeva AI Agents can be deployed quickly with high impact because they understand the Veeva application context, have application-specific prompts and safeguards, and have direct, secure access to Veeva application data, documents, and workflows. Customers can configure and extend Veeva-delivered AI Agents and build custom AI Agents to address company-specific use cases. AI Agents can be used through a chatbot user interface or called via the AI API.
Veeva AI Shortcuts empower end users with the ability to easily set up personal AI-powered automations to accomplish frequent user-specific tasks such as helping with workflows, generating insights, or researching a topic.

Veeva Adds AI to Make Drug Development and Health Research Faster and Smarter

Veeva Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) short percent of float has risen 7.41% since its last report. The company recently reported that it has 3.86 million shares sold short, which is 2.61% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.03 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Veeva Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745499625_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Veeva Systems has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Veeva Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Veeva Systems's peer group average for short interest as a percentage of float is 7.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Veeva Systems's Recent Short Interest

Piper Sandler analyst Brent Bracelin maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Overweight and lowers the price target from $290 to $255.

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Veeva Systems, Lowers Price Target to $255

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>UBS raised Mr. Cooper Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) price target from $135 to $145. UBS analyst Douglas Harter maintained a Buy rating. Mr. Cooper shares closed at $114.39 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/COOP/analyst-ratings">view this stock</a>.</li>
<li>Citigroup increased the price target for Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) from $163 to $180. Citigroup analyst Simon Hales maintained a Buy rating. Philip Morris shares closed at $160.09 on Tuesday. <a href="https://www.benzinga.com/quote/PM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel cut Marriott International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) price target from $295 to $240. Stifel analyst Simon Yarmak maintained a Hold rating. Marriott shares closed at $222.58 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/MAR/analyst-ratings">view this stock</a>.</li>
<li>Barclays raised the price target for Interactive Brokers Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) from $188 to $193. Barclays analyst Benjamin Budish maintained an Overweight rating. Interactive Brokers shares closed at $173.43 on Tuesday. <a href="https://www.benzinga.com/quote/IBKR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc cut the price target for Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) from $260 to $250. Keybanc analyst Sangita Jain maintained an Overweight rating. Veeva shares closed at $222.72 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/VEEV/analyst-ratings">view this stock</a>.</li>
<li>JP Morgan slashed Annaly Capital Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>) price target from $21 to $19. JP Morgan analyst Richard Shane maintained an Overweight rating. Annaly Capital Management shares settled at $17.96 on Tuesday. <a href="https://www.benzinga.com/quote/NLY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities cut Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) price target from $630 to $560. B of A Securities analyst Vivek Arya maintained a Buy rating. Synopsys shares closed at $425.65 on Tuesday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity slashed Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) price target from $14 to $10. Canaccord Genuity analyst George Gianarikas maintained a Buy rating. Fluence Energy shares closed at $3.6750 on Tuesday.  <a href="https://www.benzinga.com/quote/FLNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co cut the price target for Hancock Whitney Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) from $73 to $69. Stephens &amp; Co. analyst Matt Olney maintained an Overweight rating. Hancock Whitney shares settled at $48.69 on Tuesday. <a href="https://www.benzinga.com/quote/HWC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities slashed NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) price target from $200 to $160. B of A Securities analyst Vivek Arya maintained a Buy rating. Nvidia shares closed at $112.20 on Tuesday. <a href="https://www.benzinga.com/quote/NVDA/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NVDA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="603" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-1024x603.png" alt="" class="wp-image-874446" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-1024x603.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-768x452.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44811698/jim-cramer-planet-fitness-is-doing-better-than-expected-says-no-to-this-industrial-stock">Jim Cramer: Planet Fitness Is Doing Better Than Expected, Says No To This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

COOP

FLNC

IBKR

NVDA

SNPS

Nvidia To $160? Here Are 10 Top Analyst Forecasts For Wednesday

Keybanc analyst Sangita Jain maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Overweight and lowers the price target from $260 to $250.

Keybanc Maintains Overweight on Veeva Systems, Lowers Price Target to $250

Veeva Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) short percent of float has fallen 10.0% since its last report. The company recently reported that it has 3.60 million shares sold short, which is 2.43% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Veeva Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743186627_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Veeva Systems has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Veeva Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Veeva Systems's peer group average for short interest as a percentage of float is 7.26%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What Does the Market Think About Veeva Systems?

Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) has outperformed the market over the past 10 years by 14.57% on an annualized basis producing an average annual return of 25.25%. Currently, Veeva Systems has a market capitalization of $38.64 billion. 
Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 10 years ago, it would be worth $930.20 today based on a price of $237.48 for VEEV at the time of writing.
<h3>Veeva Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743107412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

On Friday, March 21, 2025, the Cathie Wood-led Ark Invest made some notable trades, including significant buys and sells.
Ark Invest's fund bought Iridium Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>), Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>), Pacific Biosciences of California Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) and Absci Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>), while selling Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), Repare Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>), Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), and Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>).
The IRDM Trade: Ark Invest&#8217;s ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>), ARK Autonomous Technology &amp; Robotics ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>), and ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) funds purchased a total of 68,355 shares of Iridium Communications Inc.
The total value of the shares bought, based on the last close price of $27.65, is approximately $1.89 million.
The BEAM Trade: Ark Invest&#8217;s ARKK and Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) funds bought a total of 28,717 shares of Beam Therapeutics Inc.
The total value of the shares bought, based on the last close price of $23.3, is approximately $669,106.
The PACB Trade: Ark Invest&#8217;s ARKK fund bought a whopping 243,300 shares of Pacific Biosciences of California Inc.
The total value of the shares bought, based on the last close price of $1.3, is approximately $316,290.
Other Key Trades:
<ul>
<li>Illumina Inc: Ark Invest sold a total of 42,616 shares through ARKK and ARKG.</li>
<li>Absci Corp: Ark Invest&#8217;s bought 71,392 shares through ARKG.</li>
<li>Repare Therapeutics: Ark Invest sold 54,786 shares through ARKG.</li>
<li>Amgen Inc: Ark Invest sold 990 shares through ARKG.</li>
<li>Veeva Systems Inc: Ark Invest sold 1,322 shares through ARKG.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44434973/tesla-record-highest-trade-ins-amid-backlash-against-ceo-elon-musk-surge-in-vandalism">Tesla Record Highest Trade-Ins Amid Backlash Against CEO Elon Musk, Surge In Vandalism</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen

JP Morgan analyst Anne Samuel maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Neutral and raises the price target from $218 to $249.

JP Morgan Maintains Neutral on Veeva Systems, Raises Price Target to $249

Indero Launches Its 40Th RTSM Study On Veeva RTSM

Scotiabank analyst Allan Verkhovski maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Sector Perform and raises the price target from $240 to $245.

Scotiabank Maintains Sector Perform on Veeva Systems, Raises Price Target to $245

Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) has outperformed the market over the past 10 years by 14.63% on an annualized basis producing an average annual return of 25.48%. Currently, Veeva Systems has a market capitalization of $37.83 billion. 
Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $9,733.72 today based on a price of $233.00 for VEEV at the time of writing.
<h3>Veeva Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741299310_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

U.S. stocks were lower, with the Dow Jones falling over 500 points on Thursday.
Shares of BJ&#8217;s Wholesale Club Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) rose sharply during Thursday's session after the company reported better-than-expected <a href="https://in.benzinga.com/news/earnings/25/03/44165337/bjs-wholesale-club-posts-q4-earnings-above-street-view-due-to-strong-membership-fee">fourth-quarter financial results</a>.
The company reported a fourth-quarter revenue decline of 1.4% year-on-year to $5.28 billion, beating the analyst consensus estimate of $5.27 billion. Adjusted EPS of 93 cents beat the consensus estimate of 87 cents.
Workday shares jumped 13.1% to $113.15 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Myers Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) shares surged 25.3% to $12.20 after the company reported better-than-expected quarterly financial results.</li>
<li>LendingTree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) shares jumped 25% to $50.35 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Studio City International Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSC#NYSE">MSC</a>) gained 18.6% to $3.2750.</li>
<li>America&#8217;s Car-Mart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) rose 16.9% to $44.85 after the company reported upbeat quarterly financial results.</li>
<li>John Wiley &amp; Sons, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>) gained 13.5% to $43.03 following better-than-expected quarterly financial results.</li>
<li>Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) rose 9.9% to $260.50 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) gained 9% to $239.73 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) rose 6.8% to $29.84.</li>
<li>Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) gained 4.9% to $43.25.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44083539/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

Intraday Update

BURL

CRMT

TREE

VKTX

BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Burlington Stores, Veeva Systems And Other Big Stocks Moving Higher On Thursday

Truist Securities analyst Joe Meares maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Hold and raises the price target from $210 to $217.

Truist Securities Maintains Hold on Veeva Systems, Raises Price Target to $217

Whales with a lot of money to spend have taken a noticeably bullish stance on Veeva Systems.
Looking at options history for Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with bullish expectations and 11% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $50,703 and 15, calls, for a total amount of $1,164,422.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $220.0 to $280.0 for Veeva Systems during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Veeva Systems stands at 719.25, with a total volume reaching 9,579.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Veeva Systems, situated within the strike price corridor from $220.0 to $280.0, throughout the last 30 days.
<h3>Veeva Systems 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741275970_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VEEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.0</td>
<td>$8.4</td>
<td>$9.0</td>
<td>$280.00</td>
<td>$488.7K</td>
<td align="right">6</td>
<td>801</td>
</tr>
<tr>
<td>VEEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.4</td>
<td>$9.3</td>
<td>$9.4</td>
<td>$280.00</td>
<td>$104.3K</td>
<td align="right">6</td>
<td>112</td>
</tr>
<tr>
<td>VEEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.0</td>
<td>$8.4</td>
<td>$9.0</td>
<td>$280.00</td>
<td>$93.6K</td>
<td align="right">6</td>
<td>258</td>
</tr>
<tr>
<td>VEEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$18.5</td>
<td>$16.2</td>
<td>$17.2</td>
<td>$220.00</td>
<td>$72.2K</td>
<td align="right">826</td>
<td>146</td>
</tr>
<tr>
<td>VEEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.0</td>
<td>$8.3</td>
<td>$9.0</td>
<td>$280.00</td>
<td>$63.0K</td>
<td align="right">6</td>
<td>1.1K</td>
</tr>
</tbody>
</table>

<h3>About Veeva Systems</h3>
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
After a thorough review of the options trading surrounding Veeva Systems, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Veeva Systems's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 989,955, the VEEV's price is up by 7.8%, now at $237.1. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 84 days.</li>
</ul>
<h3>Expert Opinions on Veeva Systems</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $259.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $270. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Underweight rating on Veeva Systems with a target price of $201. 
&#x2A; An analyst from Baird persists with their Outperform rating on Veeva Systems, maintaining a target price of $285. 
&#x2A; An analyst from Stephens &amp; Co. has revised its rating downward to Overweight, adjusting the price target to $280. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Veeva Systems with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Market Whales and Their Recent Bets on VEEV Options

Stephens &amp; Co. analyst Jeff Garro reiterates Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Overweight and maintains $280 price target.

Reiteration

Stephens & Co. Reiterates Overweight on Veeva Systems, Maintains $280 Price Target

Morgan Stanley analyst Craig Hettenbach maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Underweight and raises the price target from $195 to $201.

Morgan Stanley Maintains Underweight on Veeva Systems, Raises Price Target to $201

Baird analyst Joe Vruwink maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Outperform and raises the price target from $283 to $285.

Baird Maintains Outperform on Veeva Systems, Raises Price Target to $285

In the last three months, 9 analysts have published ratings on Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>), offering a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Veeva Systems, revealing an average target of $245.0, a high estimate of $307.00, and a low estimate of $195.00. Experiencing a 3.88% decline, the current average is now lower than the previous average price target of $254.89. 
<img src="https://www.benzinga.com/files/images/story/2025/1741266044_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Veeva Systems. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan MacDonald</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$270.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Gabriela Borges</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$200.00</td>
<td>$261.00</td>
</tr>
<tr>
<td>Ryan MacDonald</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$270.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$210.00</td>
<td>$261.00</td>
</tr>
<tr>
<td>Scott Schoenhaus</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$255.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Craig Hettenbach</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$195.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Anne Samuel</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$218.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$307.00</td>
<td>$281.00</td>
</tr>
<tr>
<td>Steven Valiquette</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$280.00</td>
<td>$275.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Veeva Systems. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Veeva Systems compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Veeva Systems's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Veeva Systems's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VEEV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Veeva Systems analyst ratings.</a>
<h2>Get to Know Veeva Systems Better</h2>
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
<h3>Veeva Systems's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3 months period, Veeva Systems showcased positive performance, achieving a revenue growth rate of 13.41% as of 31 October, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 26.57%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Veeva Systems's ROE stands out, surpassing industry averages. With an impressive ROE of 3.48%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Veeva Systems's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.91%, the company showcases efficient use of assets and strong financial health.
Debt Management: Veeva Systems's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 9 Analysts Discuss Veeva Systems Stock

Press Releases

Top Global Biopharmas Standardize on Veeva China CRM Suite

Veeva Commercial Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries

Veeva CRM Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries

Veeva Announces Fourth Quarter and Fiscal Year 2025 Results

Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform'

Indero Marks 40th Study Live with Veeva RTSM

Veeva Announces Research Site Clinical Trial Management System

Announcing Veeva AI

Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit

Veeva to Release Fiscal 2026 First Quarter Results on May 28, 2025

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

CareCloud

Certara

Claritev Corporation Class A Common Stock

Claritev

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

VSee Health

Waystar Holding

Piper Sandler

Keybanc

JP Morgan

Scotiabank

Morgan Stanley

2025년 3월 21일 금요일, 캐시 우드가 이끄는 아크 인베스트는 몇 가지 주목할 만한 거래를 진행했으며, 여기에는 상당한 매수와 매도가 포함되었다.
아크 인베스트의 펀드는 이리듐 커뮤니케이션스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>), 빔 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>), 퍼시픽 바이오사이언스 오브 캘리포니아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>), 및 앱시 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>)를 매수한 반면, 일루미나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), 리페어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>), 암젠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), 및 비바 시스템즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>)의 주식을 매도했다.
IRDM 거래: 아크 인베스트의 ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>), ARK Autonomous Technology &amp; Robotics ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>), 및 ARK Space Exploration &amp; Innovation ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) 펀드가 이리듐 커뮤니케이션스의 주식 68,355주를 총 매수했다.
마지막 종가 27.65달러를 기준으로 매수한 주식들의 총 가치는 약 189만 달러이다.
BEAM 거래: 아크 인베스트의 ARKK 및 Ark Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) 펀드가 총 28,717주의 빔 테라퓨틱스주식을 매수했다.
마지막 종가 23.3달러을 기준으로 매수한 주식들의 총 가치는 약 669,106달러이다.
PACB 거래: 아크 인베스트의 ARKK 펀드가 퍼시픽 바이오사이언스 오브 캘리포니아의 주식 243,300주를 매수했다.
마지막 종가 1.3달러를 기준으로 매수한 주식들의 총 가치는 약 316,290달러이다.
기타 주요 거래:
<ul>
<li>일루미나: 아크 인베스트는 ARKK와 ARKG를 통해 총 42,616주의 주식을 매도했다.</li>
<li>앱시 코퍼레이션: 아크 인베스트는 ARKG를 통해 71,392주의 주식을 매수했습니다.</li>
<li>리페어 테라퓨틱스: 아크 인베스트는 ARKG를 통해 54,786주의 주식을 매도했다.</li>
<li>암젠: 아크 인베스트는 ARKG를 통해 990주의 주식을 매도했다.</li>
<li>비바 시스템즈: 아크 인베스트는 ARKG를 통해 1,322주의 주식을 매도했다.</li>
</ul>
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44434973/tesla-record-highest-trade-ins-amid-backlash-against-ceo-elon-musk-surge-in-vandalism">테슬라, CEO 일론 머스크에 대한 반발과 기물 파손 급증 속 역대 최고 거래량 기록</a></li>
</ul>
면책 조항: 이 내용은 AI 도구의 도움을 받아 부분적으로 작성되었으며, Benzinga 편집자에 의해 검토되고 게시되었습니다.
사진 제공: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

목요일(6일) 아침 미국 주식 선물이 하락하는 가운데, 투자자들의 관심을 끌 수 있는 주식들이 다음과 같다.
<ul>
<li>BJ's 홀세일 클럽 홀딩스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>): 분기 주당순이익 88센트, 매출 53억 2천만 달러로 예상하고 있다. 수요일 애프터마켓에서 주식은 0.1% 하락하여 100.06달러에 거래되었다.</li>
<li>크로거(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>): 목요일 개장 전 실적을 발표할 예정이며, 분기 주당순이익 1.11달러, 매출 345억 1천만 달러로 예상한다. 수요일 애프터마켓에서 주식은 0.27% 하락한 62.36달러에 거래되었다.</li>
<li>비바 시스템즈 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>): 4분기 매출이 7억 2,090만 달러로 전년 대비 14% 증가했다고 보고했다. 이라한 매출은 애널리스트들이 예상한 6억 9,911만 달러를 초과한 수치다. 회사는 전체 회계연도 매출 가이던스를 30억 4천만 달러에서 30억 5천 5백만 달러 사이로 제시했으며, 애널리스트 예상치 30억 5천 5백만 달러와 일치한다. 회사는 전체 연도 주당순이익(EPS)을 7.32달러로 전망했고, 이는 애널리스트 예상치 6.91달러를 초과하는 수치다. 주식은 수요일 애프터마켓에서 7.16% 상승한 235.69달러에 거래되었다.</li>
</ul>
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 보도</a>를 확인하세요.
<ul>
<li>메이시스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>): 목요일 개장 전 실적을 발표할 예정이며, 분기 주당순이익 1.53달러, 매출 78억 7천만 달러로 예상된다. 주식은 수요일 애프터마켓에서 0.5% 상승한 13.37달러에 거래되었다.</li>
<li>휴렛 팩커드 엔터프라이즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>): 목요일 폐장 후 실적을 발표할 예정이며, 분기 주당순이익 49센트 매출 78억 2천만 달러로 예상된다. 주식은 수요일 애프터마켓에서 0.3% 상승한 18.89달러에 거래되었다.</li>
</ul>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

목요일 주목해야 할 주식: 크로거, BJ's 홀세일 클럽, 비바 시스템즈, 메이시스 및 휴렛 팩커드 엔터프라이즈

원격 근무와 사무실 근무 의무에 대한 논쟁이 계속되는 가운데, 비바 시스템즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>), 클라우드 기반 소프트웨어 회사가 주목받고 있습. 이는 원격 근무(WFH) 정책을 수용하는 것이 어떻게 <a href="https://www.benzinga.com/top-stories/24/09/40887347/amazon-to-cut-management-layers-end-work-from-home" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">성공적인 전략이 될 수 있는지</a>를 보여주는 대표적인 사례이다.
비바는 2024년 원격 채용 공고가 가장 많았으며 연간 급여가 55,000~300,000달러에 달하는 역할을 제공했다고 포춘(Fortune)이 <a href="https://fortune.com/2025/01/24/veeva-most-remote-job-postings-wfh-rto/" target="_blank" rel="noreferrer noopener">보도</a>하며 플렉스잡스(FlexJobs)를 인용했다. 이는 유연성을 추구하는 구직자들에게 회사를 매우 매력적으로 만들었다. 특히 고용 시장이 보수가 좋은 원격 기회에 여전히 굶주려 있기 때문에 더욱 그렇다.
원격 근무가 주식 수익률을 높일까?
비바의 원격 근무 성공 사례는 직원들에게만 이로운 것이 아니라, 포춘이 덧붙인 바와 같이 건전한 비즈니스 전략이기도 하다. 연구에 따르면, 원격 근무 옵션을 제공하는 회사들이 더 나은 주식 수익률을 기록하고 더 높은 질의 인재를 유치하는 경향이 있다.
멜버른 대학교의 금융학 조교수 가브리엘레 라탄지오(Gabriele Lattanzio)가 발표한 <a href="https://editorialexpress.com/cgi-bin/conference/download.cgi?db_name=SIEP2021&amp;paper_id=58" target="_blank" rel="noreferrer noopener">논문</a>에 따르면, 원격 근무를 제공하는 회사들이 시장을 초과하여 7.44% 더 높은 수익률을 기록했다.
이러한 회사들은 또한 더 좋은 수익 결과와 긍정적인 주가 반응을 보였다.
<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">벤징가 프로</a>에 따르면, VEEV 주식은 지난 1년 동안 7% 이상 상승했다. 투자자들은 First Trust Nasdaq Lux Digital Health Solutions ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKG#NASDAQ">EKG</a>)를 통해 이 주식에 투자할 수 있다.
비바의 원격 근무 유연성 vs JP모건의 사무실 의무:
2007년에 설립된 비바의 원격 중심 접근 방식은 회사의 문화에 처음부터 뿌리내려 있었다. 창립자들이 회사 초기 몇 년 동안 서로 다른 도시에서 운영되었기 때문이다.
하지만 비바의 전략은 직원의 반발에 직면한 JP모건 체이스 &amp; 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>)와는 뚜렷한 대조를 이룬다. JP모건은 최근 직원들에게 주 5일 사무실 복귀를 요구하는 의무를 부과하여 큰 반발을 사고 있다. 이는 포춘이 이달 초 보도한 바 있다.
JPM 주식은 지난 1년 동안 53% 이상 상승했다. 투자자들은 iShares U.S. Financial Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYG#NYSE">IYG</a>)를 통해 이 주식에 투자할 수 있다.
실제로 알파벳(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), 마이크로소프트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) 및 골드만삭스 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>)과 같은 주요 기업들은 직원들의 광범위한 저항에도 불구하고 사무실 복귀(RTO) 정책을 추진하고 있다.
이 회사의 직원들은 불만을 표시하며, 일부는 청원이나 퇴사를 통해 항의하기도 했다고 포춘이 덧붙였다.
일의 미래: 원격 근무가 자리잡을 수 있을까?
연구에 따르면, 주 2일 재택 근무를 하는 직원들은 매일 사무실에 출근하는 직원들과 동일한 생산성을 보인다고 한다. 이는 포브스가 Resume.org의 설문조사를 인용하여 보도한 내용이다. 그럼에도 불구하고, 28%의 비즈니스 리더가 2025년까지 100% 대면 근무를 강제할 계획인 반면, 2%만이 주 1일 미만의 사무실 근무를 허용할 것이다.
일의 미래가 진화함에 따라, 비바의 원격 근무를 통한 직원 행복과 생산성에 대한 집중은 점점 더 경쟁이 치열해지는 노동 시장에서 회사를 차별화하고 있다.

다음 읽기:
<a href="https://www.benzinga.com/markets/equities/25/01/43216784/doug-ford-takes-on-trump-ontario-premier-threatens-swift-retaliation-in-trade-war">더그 포드가 트럼프에게 도전: 온타리오 주지사가 무역 전쟁에서 신속한 보복을 위협합니다</a>
이미지 출처: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 어펌 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>)의 주가는 강력한 4분기 실적과 낙관적인 <a href="https://www.benzinga.com//node/40613433" target="_blank" rel="noreferrer noopener">1분기 가이던스</a>에 따라 36.04% 상승했다. 몇몇 분석가는 <a href="https://www.benzinga.com//node/40630056" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정</a>했다.
2. 뉴타닉스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>)는 회사가 4분기 재무 결과를 보고하고 1분기 및 2025 회계연도 <a href="https://www.benzinga.com//node/40614905" target="_blank" rel="noreferrer noopener">매출 가이던스를 예상치</a>보다 높게 발표한 후 18.80% 상승했다. 많은 분석가들이 <a href="https://www.benzinga.com//node/40626089" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정</a>했다.
3. 몽고DB(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>)는 예상보다 나은 2분기 재무 결과와 강력한 지침을 발표하여 지난주 주가가 16.32% 상승했다. 몇몇 분석가들이 <a href="https://www.benzinga.com/quote/MDB/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정</a>했다.
4. 베스트 바이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>)가 2분기 실적을 보고하고 <a href="https://www.benzinga.com//node/40624075" target="_blank" rel="noreferrer noopener">2025 회계연도 실적 가이던스를 상향 조정</a>한 후 주가는 13.54% 상승했다. 몇몇 분석가들은 <a href="https://www.benzinga.com//node/40651188" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주식에 대한 전망을 높였다</a>.
5. GE 베르노바(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>)의 주식은 투자 은행 윌리엄 블레어(William Blair)가 주식을 <a href="https://www.benzinga.com/quote/GEV/analyst-ratings" target="_blank" rel="noreferrer noopener">아웃퍼폼 등급으로 커버리지를 개시</a>한 후 11.62% 상승했다.
6. 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/40564652" target="_blank" rel="noreferrer noopener">분기 실적을 발표</a>한 후 11.42% 상승했다.
7. 쿠퍼 컴퍼니스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>)의 주식은 3분기 실적을 발표하고 예상치를 상회하는 <a href="https://www.benzinga.com//node/40611992" target="_blank" rel="noreferrer noopener">4분기 및 2025 회계연도 가이던스를 발표</a>한 후 11.30% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/COO/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정</a>했다.
8. 인슐렛 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>)의 주식은 최근 자사의 패치형 웨어러블 인슐린 펌프인 옴니팟(Omnipod)이 <a href="https://www.benzinga.com//node/40562757" target="_blank" rel="noreferrer noopener">미국에서 제2형 당뇨병 환자</a>에게 사용하도록 지정되었다고 발표한 후 주가는 9.94% 상승했다.
9. 비바 시스템즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>)의 주식은 회사가 재무 실적을 발표하고 3분기 및 2025 회계연도 조정 <a href="https://www.benzinga.com//node/40611557" target="_blank" rel="noreferrer noopener">EPS 가이던스를 예상치 이상으로 발표</a>한 후 8.44% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/veev/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정</a>했다.
10. 아스펜 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZPN#NASDAQ">AZPN</a>)의 주식은 8.12% 상승했다.
다음 읽기:
<a href="https://kr.benzinga.com/news/usa/stocks/%eb%8b%ac%eb%9f%ac-%ec%a0%9c%eb%84%88%eb%9f%b4-%eb%b0%8f-%ed%85%8c%eb%ac%b4%ec%9d%98-%eb%aa%a8%ed%9a%8c%ec%82%ac-pdd%eb%8a%94-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ec%95%85%ec%9d%98-%ec%84%b1%ea%b3%bc/" target="_blank" rel="noopener">달러 제너럴 및 PDD는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (8월 25일-8월 31일)</a>
Affirm 제공
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Veeva Systems

뉴스

에 대한 최신 뉴스 Veeva Systems (NYSE:VEEV) 주식

토요일, 3월 22, 2025

목요일, 3월 06, 2025

월요일, 1월 27, 2025

화요일, 9월 03, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌